Sulindac



Sulindac





(sul in’ dak)

Apo-Sulin (CAN), Clinoril

PREGNANCY CATEGORY B (FIRST AND SECOND TRIMESTERS)

PREGNANCY CATEGORY D (THIRD TRIMESTER)


Drug Classes

Analgesic

Antipyretic

NSAID


Therapeutic Actions

Anti-inflammatory, analgesic, and antipyretic activities largely related to inhibition of prostaglandin synthesis; exact mechanisms of action are not known.


Indications



  • Acute or long-term use to relieve signs and symptoms of osteoarthritis, rheumatoid arthritis, acute gouty arthritis


  • Acute or long-term use in relief of signs and symptoms of ankylosing spondylitis, acute painful shoulder


  • Unlabeled use: Treatment of juvenile rheumatoid arthritis



Available Forms

Tablets—150, 200 mg


Dosages

Do not exceed 400 mg/day.

Adults



  • Rheumatoid arthritis or osteoarthritis, ankylosing spondylitis: Initial dose of 150 mg bid PO; maximum dose, 400 mg/day. Individualize dosage.


  • Acute painful shoulder, acute gouty arthritis: 200 mg bid PO; maximum dose, 400 mg/day. After adequate response, reduce dosage. Acute painful shoulder usually requires 7–14 days of therapy; acute gouty arthritis, 7 days.

Pediatric patients

Safety and efficacy not established.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Sulindac

Full access? Get Clinical Tree

Get Clinical Tree app for offline access